BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed INSM catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:95bb6933ba3bc45ef03b@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:INSM P2/P3 readout (est.): An Extension Study of Treprostinil Palmi
 til Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)
DESCRIPTION:An Extension Study of Treprostinil Palmitil Inhalation Powder (
 TPIP) for Pulmonary Arterial Hypertension (PAH)\nNCT05649748 | PHASE2/PHAS
 E3 | ACTIVE_NOT_RECRUITING | sponsor: Insmed Incorporated\nPrimary complet
 ion date (ESTIMATED)\; top-line results usually follow later.\nTicker INSM
  (confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT05649748\nS
 cheduling/reference data from public records\; dates can move. Not investm
 ent\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05649748
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
